Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Gumbo,I have a problem with your Cybor cite and ITC advantage.

Sorry for the prior incomplete post.

I should also have mentioned that ITC factual findings are reviewed under the deferential “substantial evidence” standard. This was established in Spansion, Inc. v. ITC, 629 F.3d 1331, 1343 (Fed. Cir. 2010).

So, again, the ITC claim construction will be provided deference while the district court will not. It probably makes some difference, but I don't know how significant in reality it is.

Share
New Message
Please login to post a reply